| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/JTO.0000000000000518 |
| P698 | PubMed publication ID | 26134234 |
| P50 | author | Wei-Yu Liao | Q57020031 |
| P2093 | author name string | Jin-Yuan Shih | |
| Yi-Nan Liu | |||
| Chien-Hung Gow | |||
| P433 | issue | 7 | |
| P304 | page(s) | e58-60 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
| P1476 | title | Discordant HER2 Exon 20 Mutation Status Determines a Differential Sensitivity to Afatinib | |
| P478 | volume | 10 |
| Q58092149 | Afatinib as first-line treatment for advanced lung adenocarcinoma patients harboring HER2 mutation: A case report and review of the literature |
| Q60307729 | Clinical benefit from afatinib in an advanced squamous cell lung carcinoma patient harboring S310Y mutation: a case report |
| Q39034581 | Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas |
| Q90941054 | Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion |
| Q38653045 | Emerging targeted therapies in non-small cell lung cancer |
| Q38990576 | Novel EGFR Inhibitors in Non-small Cell Lung Cancer: Current Status of Afatinib. |
| Q42369856 | Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer |
Search more.